Every price names its source
No sponsorships, referrals or clinic partnerships
EpiPen, insulin & Ozempic prices refreshed October 2026
Cost comparison only — not medical advice
Every price names its source
No sponsorships, referrals or clinic partnerships
EpiPen, insulin & Ozempic prices refreshed October 2026
Cost comparison only — not medical advice
← All Articles
Drug Prices

Otezla Price by Country: $5,590 in the US, about $438 in Switzerland

Europe already has generic apremilast. Here is what 60 tablets of 30 mg — 30 days — cost in eight places, brand and generic.

November 2026 · Updated November 9, 2026 · By Wellness Vision 5 min read 19 sources

Researched with AI assistance; every figure is checked against the primary source cited on this page before publishing. How we work →

Key Takeaways

  • The US list price rose 18% since 2024. Amgen lists 60 tablets of Otezla 30 mg at $5,589.89 (September 8, 2026); CMS recorded $4,722 for a 30-day supply in 2024 (our calculation: $5,589.89 ÷ $4,722). US pharmacies’ cost per tablet rose 5% on January 7, 2026 (CMS NADAC).
  • $1,650 for Medicare from 2027. Medicare’s negotiated price for a 30-day supply takes effect on January 1, 2027 — 65% below the 2024 list price, according to CMS. Per 30 mg tablet it is $28.57, or $1,714 for 60 tablets (our calculation).
  • Europe, brand Otezla: about $438 to $789 for 30 days. Official prices for 60 tablets, scaled from packs of 56 and converted at ECB rates: Switzerland $438, France $453, the Netherlands $547, Austria $559, the UK $789 (our calculation).
  • Generics cost less still. Generic apremilast is listed at €134.80 for 56 tablets in Austria (about $161 for 60), €183.93 in France and CHF 259.85 in Switzerland. The US pharmacy price survey (NADAC) lists no generic yet.

Otezla / Apremilast 30 mg Price by Country (November 2026)

Otezla 30 mg (apremilast) is taken twice a day for psoriasis, psoriatic arthritis or Behçet’s mouth ulcers after a five-day starter schedule (FDA label) — so 30 days = 60 tablets. European packs hold 56 tablets; we scale to 60 (our calculation: pack price ÷ 56 × 60). Where a generic is listed, we show it as well. US dollars at European Central Bank reference rates of November 6, 2026. The price types differ — list price, negotiated price, pharmacy acquisition cost, retail price — and are labelled.

30 days = 60 tablets of 30 mg. US: Amgen list price (September 8, 2026), CMS data file ($28.571974 per tablet from 2027 × 60, our calculation), CMS NADAC (as of November 4, 2026). UK: NHS Drug Tariff. France: public medicines database. Switzerland: BAG public price. Austria: Erstattungskodex, November 2026 (excl. VAT). Netherlands: Zorginstituut average price (to November 1, 2026). Packs of 56 scaled to 60 tablets; converted at ECB rates of November 6, 2026 (our calculation).
CountryOfficial price30 days in US dollarsWhat a patient typically pays
🇺🇸 United States (list)$5,589.89 for 60 × 30 mg (Amgen, as of Sep 8, 2026)$5,590Commercially insured patients may pay as little as $0 a month with the co-pay program; not for Medicare or Medicaid (maker’s terms)
🇺🇸 United States (pharmacy cost)$90.58800 per 30 mg tablet (CMS NADAC, Nov 4, 2026)$5,435—
🇺🇸 United States (Medicare, 2027)$1,650 negotiated price per 30-day supply, from Jan 1, 2027 (CMS); $28.571974 per tablet$1,714Depends on the Part D plan and coverage phase
🇬🇧 United KingdomApremilast 30 mg £550.00 for 56 tablets (NHS Drug Tariff price, since Jan 1, 2019; Otezla the same); generic suppliers list from £96.25$789£9.90 per item in England; free in Scotland, Wales and Northern Ireland
🇨🇭 SwitzerlandOtezla CHF 334.85 for 56 tablets; generic CHF 259.85 (public prices; limitation)$438 (generic $340)10% share after the annual deductible
🇫🇷 FranceOtezla €378.83 for 56 tablets; generic €183.93 (official prices excluding dispensing fee)$453 (generic $220)70% of the price unless a complementary insurer covers it (30% reimbursed)
🇳🇱 NetherlandsOtezla €457.44 for 56 tablets; generic (HCS) €207.10 (average pharmacy prices)$547 (generic $248)Fully reimbursed; counts toward the annual deductible
🇦🇹 AustriaOtezla €467.35 for 56 tablets; generic €134.80 (social-insurance prices excl. VAT)$559 (generic $161)€7.55 prescription fee per pack; Otezla needs insurer approval first
🇩🇪 GermanyNo statutory price ceiling (Festbetrag) for apremilast; no official price found——

We compare prices; we do not recommend where to buy medicine. Whether to switch between brand and generic is a decision for your doctor and pharmacist.

What the Numbers Mean

Medicare’s price takes effect in 2027

The $1,650 is the price Medicare negotiated for Otezla and Otezla XR under the Inflation Reduction Act, effective January 1, 2027. CMS’s data file sets $28.571974 per 30 mg tablet, or $1,714 for 60 tablets (our calculation). In 2024 about 31,000 people with Medicare Part D used Otezla, and Part D spent $1.05 billion on it before rebates (CMS). Amgen’s $0 co-pay program excludes Medicare and Medicaid.

Europe: brand Otezla at 8% to 14% of the US list price

Switzerland, France, the Netherlands, Austria and the UK publish an official price for Otezla 30 mg — about $438 to $789 for 60 tablets at ECB rates, or 8% to 14% of the US list price (our calculation: $438 ÷ $5,590 and $789 ÷ $5,590). Medicare’s 2027 price is still about three times the Austrian price for the brand (our calculation: $1,714 ÷ $559).

Generics arrived in Europe first

Austria lists generic apremilast at €134.80 for 56 tablets, France at €183.93, Switzerland at CHF 259.85 and the Netherlands from €207.10; in the UK, generic suppliers list prices from £96.25, although the NHS Drug Tariff still pays £550.00. The US pharmacy price survey (NADAC, November 4, 2026) lists only Otezla.

Frequently Asked Questions

How much does Otezla cost in the US compared with other countries?

Amgen lists 60 tablets of Otezla 30 mg at $5,589.89 (September 8, 2026), and US pharmacies paid about $5,435 in November 2026 (CMS NADAC). Medicare’s negotiated price from January 1, 2027 is $1,650 for a 30-day supply (CMS). In Europe, 56 tablets of Otezla cost CHF 334.85 in Switzerland, €378.83 in France, €457.44 in the Netherlands, €467.35 in Austria (excl. VAT) and £550.00 in the UK — about $438 to $789 for 60 tablets at ECB rates.

Is there a generic Otezla?

In Europe, yes: generic apremilast is listed at €134.80 for 56 tablets in Austria, €183.93 in France, CHF 259.85 in Switzerland and from €207.10 in the Netherlands. The US pharmacy price survey (NADAC, November 4, 2026) lists only Otezla.

Why does the UK pay £550 if generics cost less?

The NHS Drug Tariff price for apremilast 30 mg is £550.00 for 56 tablets (Category C, since January 1, 2019). Generic suppliers list their own prices in dm+d, some from £96.25, but the Drug Tariff price is what the NHS pays pharmacies for the product.

What do patients pay?

In the US, commercially insured patients may pay as little as $0 a month with Amgen’s co-pay program, which excludes Medicare and Medicaid. In England each prescription item costs £9.90; in Switzerland insured patients pay a 10% share after the deductible; in France 30% is reimbursed; in Austria a €7.55 prescription fee; in the Netherlands it is fully reimbursed but counts toward the annual deductible.

How many tablets does 30 days take?

After a five-day starter schedule, the label dose is 30 mg twice a day, so 60 tablets for 30 days; Otezla XR is one 75 mg tablet a day, and Amgen lists 30 XR tablets at the same $5,589.89 (FDA label, Amgen).

Sources

  1. Amgen — Otezla list pricing: 30 mg tablets × 60, current WAC $5,589.89 per bottle; 75 mg XR × 30 the same; accurate as of September 8, 2026
  2. CMS — Negotiated prices for initial price applicability year 2027 (fact sheet, November 2025): Otezla; Otezla XR $1,650 negotiated price for a 30-day supply, $4,722 list price (2024), 65% lower; 31,000 Part D enrollees, $1,045,443,000 gross Part D costs in 2024
  3. CMS — Selected drug list and maximum fair price data file (November 2, 2026): Otezla 30 mg $28.571974 per tablet from January 1, 2027
  4. CMS — Medicare Drug Price Negotiation Program: final guidance and effectuation of the negotiated price
  5. CMS — NADAC, as of November 4, 2026: Otezla 30 mg $90.58800 per tablet (effective October 21, 2026); $86.38028 effective December 17, 2025, $90.69930 effective January 7, 2026; no generic apremilast
  6. DailyMed — Otezla prescribing information: maintenance dosage 30 mg twice daily or Otezla XR 75 mg once daily
  7. Amgen — Otezla co-pay program: commercially insured patients may pay as little as $0 a month; not for Medicare or Medicaid patients
  8. NHS dm+d — Apremilast 30 mg tablets, 56: Drug Tariff Category C £550.00 (since January 1, 2019); Otezla (Amgen) £550.00
  9. NHS dm+d — apremilast 30 mg suppliers: generic list prices from £96.25 for 56 tablets (2026)
  10. NHS Business Services Authority — prescription charge £9.90 per item (England)
  11. Base de données publique des médicaments — Otezla 30 mg, 56 tablets: €378.83 excluding dispensing fee, 30% reimbursed; Apremilast Accord and Arrow 30 mg, 56 tablets: €183.93 (bulk files of November 6, 2026)
  12. Federal Office of Public Health (BAG) — Spezialitätenliste: Otezla 30 mg, 56 tablets, CHF 334.85; Apremilast Accord and Leman CHF 259.85; cost share 10%; limitation
  13. Austrian social insurance (Dachverband) — Erstattungskodex monthly data, November 2026: Otezla 30 mg, 56 tablets, €467.35 (yellow box, RE1); generic apremilast 30 mg, 56 tablets, €134.80 (green box, IND); excl. VAT
  14. oesterreich.gv.at — prescription fee (Rezeptgebühr) €7.55 per pack since January 1, 2026
  15. Zorginstituut Nederland — Medicijnkosten.nl: Otezla 30 mg (EU/1/14/981/002), average price €457.44 per pack, €8.17 per tablet, fully reimbursed (updated to November 1, 2026)
  16. Zorginstituut Nederland — Medicijnkosten.nl: Apremilast HCS 30 mg, €207.10 per pack, €3.70 per tablet
  17. European Medicines Agency — Otezla product information: EU/1/14/981/002 = 56 film-coated tablets
  18. BfArM / GKV-Spitzenverband — Festbetrag list as of November 1, 2026 (no entry for apremilast)
  19. European Central Bank — reference rates, November 6, 2026 (1 US dollar = €0.89566 = £0.74711 = CHF 0.8189)

Related Cost Comparisons

Wellness Vision Editorial Policy

Wellness Vision does not sell medicine, recommend pharmacies or suppliers, or take payments from drug makers. Every price above comes from the official source cited; currency conversions and 30-day figures are our own calculations, shown with their formula. This is a cost comparison, not medical advice.

You shouldn't have to go broke to feel whole.